AU2017900163A0 - Novel glycine transport inhibitors for the treatment of pain - Google Patents

Novel glycine transport inhibitors for the treatment of pain

Info

Publication number
AU2017900163A0
AU2017900163A0 AU2017900163A AU2017900163A AU2017900163A0 AU 2017900163 A0 AU2017900163 A0 AU 2017900163A0 AU 2017900163 A AU2017900163 A AU 2017900163A AU 2017900163 A AU2017900163 A AU 2017900163A AU 2017900163 A0 AU2017900163 A0 AU 2017900163A0
Authority
AU
Australia
Prior art keywords
pain
treatment
transport inhibitors
glycine transport
novel glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900163A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Technology Sydney
University of Sydney
Original Assignee
University of Technology Sydney
University of Sydney
Filing date
Publication date
Application filed by University of Technology Sydney, University of Sydney filed Critical University of Technology Sydney
Publication of AU2017900163A0 publication Critical patent/AU2017900163A0/en
Priority to PCT/AU2018/050035 priority Critical patent/WO2018132876A1/en
Abandoned legal-status Critical Current

Links

AU2017900163A 2017-01-19 2017-01-19 Novel glycine transport inhibitors for the treatment of pain Abandoned AU2017900163A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2018/050035 WO2018132876A1 (en) 2017-01-19 2018-01-19 Novel glycine transport inhibitors for the treatment of pain

Publications (1)

Publication Number Publication Date
AU2017900163A0 true AU2017900163A0 (en) 2017-02-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP3397963A4 (en) Inhibition of p38 mapk for the treatment of cancer
EP3180009A4 (en) Zoledronic acid dosage forms for the treatment of pain
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
IL275482A (en) Esketamine for the treatment of depression
EP3790867A4 (en) Kdm1a inhibitors for the treatment of disease
IL283948A (en) Methods for the treatment of depression
EP3585376A4 (en) Calcium channel inhibitors
IL276482A (en) Compounds for the treatment of pain
EP3621600A4 (en) Methods for the treatment of recurrent glioblastoma (rgbm)
EP3285767B8 (en) Treatment of pain
GB201506654D0 (en) Formulations for inhibition of PCSK9 for the treatment of hypercholesterolemia
IL283885A (en) Cxcr7 inhibitors for the treatment of cancer
EP3224263A4 (en) Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
PL3448340T3 (en) Application aid for the treatment of wounds
EP3458062A4 (en) Treatment of pain
EP3840748A4 (en) Substituted imidazoles for the inhibition of tgf-beta and methods of treatment
EP3723781A4 (en) Peptides and other agents for treating pain and increasing pain sensitivity
EP3532045A4 (en) Use of senicapoc for treatment of neuropathic pain
EP3471701A4 (en) Wound healing using braf inhibitors
EP3373947A4 (en) Compounds and methods for treating pain
EP3873528A4 (en) Rasopathy treatment
EP3793999A4 (en) Pain treating compounds and uses thereof
AU2017900163A0 (en) Novel glycine transport inhibitors for the treatment of pain
EP3615052A4 (en) Use of hcn inhibitors for treatment of cancer
EP3668975A4 (en) Compositions and methods for amino acid depletion therapy